With December's trading concluded, AMD stock closed out 2024 down roughly 18%. The chip specialist's share price fell in the final month of 2024 as analysts became more cautious about the stock and ...

Chip designer AMD said Wednesday that it will invest $20 million in Absci, the Vancouver company that aims to use artificial intelligence to develop new drug therapies.

Intel's Arc B570 GPU is ready for launch, featuring Xe2 cores, 10GB VRAM, and AI-powered Frame Generation. Discover its specs ...

Strategists at HSBC led by Frank Lee lowered their price target on the shares to $110 from $200 and cut the rating to Reduce ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

Advanced Micro Devices Inc. (AMD) stock tumbled more than 3% in pre-market trading on Wednesday after HSBC analysts double ...

Shares of Absci on Wednesday jumped following a report on a $20 million investment from Advanced Micro Devices. The stock was up 27% to $3.89 in pre-market trading. Through Tuesday's close, shares ...

Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, today announced a strategic collaboration with AMD to deploy AMD Instinct™ accelerators and ROCm™ software to power ...

Micron invests $7 billion in Singapore's first high-bandwidth memory (HBM) facility to support growing AI demand.

Catch up on the clinical trial news, updates from the United States Food and Drug Administration (FDA), and company funding ...

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other industries.

Nvidia launched its 50-series line-up of graphics cards. But when it comes to GPU, it's always a question of AMD vs. Nvidia.